<i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant
As an important zoonotic protozoan, <i>Toxoplasma gondii</i> (<i>T. gondii</i>) has spread around the world, leading to infections in one-third of the population. There is still no effective vaccine or medicine against <i>T. gondii</i>, and recombinant antigens en...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/5/752 |
| _version_ | 1797533513351692288 |
|---|---|
| author | Zhengqing Yu Wenxi Ding Muhammad Tahir Aleem Junzhi Su Junlong Liu Jianxun Luo Ruofeng Yan Lixin Xu Xiaokai Song Xiangrui Li |
| author_facet | Zhengqing Yu Wenxi Ding Muhammad Tahir Aleem Junzhi Su Junlong Liu Jianxun Luo Ruofeng Yan Lixin Xu Xiaokai Song Xiangrui Li |
| author_sort | Zhengqing Yu |
| collection | DOAJ |
| description | As an important zoonotic protozoan, <i>Toxoplasma gondii</i> (<i>T. gondii</i>) has spread around the world, leading to infections in one-third of the population. There is still no effective vaccine or medicine against <i>T. gondii</i>, and recombinant antigens entrapped within nanospheres have benefits over traditional vaccines. In the present study, we first expressed and purified <i>T. gondii</i> proteasome subunit alpha type 1 (TgPSA1), then encapsulated the recombinant TgPSA1 (rTgPSA1) in chitosan nanospheres (CS nanospheres, rTgPSA1/CS nanospheres) and incomplete Freund’s adjuvant (IFA, rTgPSA1/IFA emulsion). Antigens entrapped in CS nanospheres reached an encapsulation efficiency of 67.39%, and rTgPSA1/CS nanospheres showed a more stable release profile compared to rTgPSA1/IFA emulsion in vitro. In vivo, Th1-biased cellular and humoral immune responses were induced in mice and chickens immunized with rTgPSA1/CS nanospheres and rTgPSA1/IFA emulsion, accompanied by promoted production of antibodies, IFN-γ, IL-4, and IL-17, and modulated production of IL-10. Immunization with rTgPSA1/CS nanospheres and rTgPSA1/IFA emulsion conferred significant protection, with prolonged survival time in mice and significantly decreased parasite burden in chickens. Furthermore, our results also indicate that rTgPSA1/CS nanospheres could be used as a substitute for rTgPSA1/IFA emulsion, with the optimal administration route being intramuscular in mass vaccination. Collectively, the results of this study indicate that rTgPSA1/CS nanospheres represent a promising vaccine to protect animals against acute toxoplasmosis. |
| first_indexed | 2024-03-10T11:16:35Z |
| format | Article |
| id | doaj.art-ddd5505f2cc441d09c6d2ec58d66cd6c |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T11:16:35Z |
| publishDate | 2021-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-ddd5505f2cc441d09c6d2ec58d66cd6c2023-11-21T20:26:39ZengMDPI AGPharmaceutics1999-49232021-05-0113575210.3390/pharmaceutics13050752<i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional AdjuvantZhengqing Yu0Wenxi Ding1Muhammad Tahir Aleem2Junzhi Su3Junlong Liu4Jianxun Luo5Ruofeng Yan6Lixin Xu7Xiaokai Song8Xiangrui Li9MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, ChinaState Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaMOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210000, ChinaAs an important zoonotic protozoan, <i>Toxoplasma gondii</i> (<i>T. gondii</i>) has spread around the world, leading to infections in one-third of the population. There is still no effective vaccine or medicine against <i>T. gondii</i>, and recombinant antigens entrapped within nanospheres have benefits over traditional vaccines. In the present study, we first expressed and purified <i>T. gondii</i> proteasome subunit alpha type 1 (TgPSA1), then encapsulated the recombinant TgPSA1 (rTgPSA1) in chitosan nanospheres (CS nanospheres, rTgPSA1/CS nanospheres) and incomplete Freund’s adjuvant (IFA, rTgPSA1/IFA emulsion). Antigens entrapped in CS nanospheres reached an encapsulation efficiency of 67.39%, and rTgPSA1/CS nanospheres showed a more stable release profile compared to rTgPSA1/IFA emulsion in vitro. In vivo, Th1-biased cellular and humoral immune responses were induced in mice and chickens immunized with rTgPSA1/CS nanospheres and rTgPSA1/IFA emulsion, accompanied by promoted production of antibodies, IFN-γ, IL-4, and IL-17, and modulated production of IL-10. Immunization with rTgPSA1/CS nanospheres and rTgPSA1/IFA emulsion conferred significant protection, with prolonged survival time in mice and significantly decreased parasite burden in chickens. Furthermore, our results also indicate that rTgPSA1/CS nanospheres could be used as a substitute for rTgPSA1/IFA emulsion, with the optimal administration route being intramuscular in mass vaccination. Collectively, the results of this study indicate that rTgPSA1/CS nanospheres represent a promising vaccine to protect animals against acute toxoplasmosis.https://www.mdpi.com/1999-4923/13/5/752<i>Toxoplasma gondii</i>proteasome subunit alpha type 1incomplete Freund’s adjuvantchitosanimmune protectionmouse |
| spellingShingle | Zhengqing Yu Wenxi Ding Muhammad Tahir Aleem Junzhi Su Junlong Liu Jianxun Luo Ruofeng Yan Lixin Xu Xiaokai Song Xiangrui Li <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant Pharmaceutics <i>Toxoplasma gondii</i> proteasome subunit alpha type 1 incomplete Freund’s adjuvant chitosan immune protection mouse |
| title | <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant |
| title_full | <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant |
| title_fullStr | <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant |
| title_full_unstemmed | <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant |
| title_short | <i>Toxoplasma gondii</i> Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant |
| title_sort | i toxoplasma gondii i proteasome subunit alpha type 1 with chitosan a promising alternative to traditional adjuvant |
| topic | <i>Toxoplasma gondii</i> proteasome subunit alpha type 1 incomplete Freund’s adjuvant chitosan immune protection mouse |
| url | https://www.mdpi.com/1999-4923/13/5/752 |
| work_keys_str_mv | AT zhengqingyu itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT wenxiding itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT muhammadtahiraleem itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT junzhisu itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT junlongliu itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT jianxunluo itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT ruofengyan itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT lixinxu itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT xiaokaisong itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant AT xiangruili itoxoplasmagondiiiproteasomesubunitalphatype1withchitosanapromisingalternativetotraditionaladjuvant |